Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: In vitro and in vivo study

Croatian Medical Journal

Volumn 55, Issue 3, 2014, Pages 206-217

  Panchuk, Rostyslav ^a   Skorokhyd, Nadia ^a   Chumak, Vira ^a,b   Lehka, Lilya ^a   Omelyanchik, Sofya ^c   Gurinovich, Valery ^c   Moiseenok, Andrey ^c   Heffeter, Petra ^d   Berger, Walter ^d   Stoika, Rostyslav ^a,b  

^a INSTITUTE OF CELL BIOLOGY   (Ukraine)

^b IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

^c INSTITUTE FOR MATHEMATICS   (Belarus)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COENZYME A; DOXORUBICIN; OXYGEN RADICAL; PANTETHINE; PROTEIN BAX; PROTEIN P53; SELENOMETHIONINE; SODIUM SELENITE; SUCCINATE DEHYDROGENASE; SUPEROXIDE;

ADULT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CARCINOMA CELL; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RESISTANCE; ENZYME ACTIVITY; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LC 50; LEUKEMIA CELL; LIVER; MALE; MODULATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PLASMA; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CISPLATIN; DOXORUBICIN; DRUG SYNERGISM; HCT116 CELLS; HL-60 CELLS; HUMANS; JURKAT CELLS; MALE; OXIDATION-REDUCTION; OXIDOREDUCTASES; PANTETHEINE; RATS; RATS, WISTAR; SELENOMETHIONINE; SODIUM SELENITE; TUMOR CELLS, CULTURED;

EID: 84901836256     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2014.55.206     Document Type: Article

References (31)

1. Aguilar F, Charrondiere UR, Dusemund B, Galtier P, Gilbert J, Gott DM, et al. L-selenomethionine as a source of selenium added for nutritional purposes to food supplements. The EFSA Journal. 2009;1082:1-39.
2. Berndtsson M, Hägg M, Panaretakis T, Havelka AM, Shoshan MC, Linder S. Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int J Cancer. 2007;120:175-80. Medline:17044026 doi:10.1002/ijc.22132
3. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185-229. Medline:15169927 doi:10.1124/pr.56.2.6
4. Menna P, Paz OG, Chello M, Covino E, Salvatorelli E, Minotti G. Anthracycline cardiotoxicity. Expert Opin Drug Saf. 2012;11 Suppl 1:S21-36. Medline:21635149 doi:10.1517/14740338.2011.589834
5. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Pérez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem. 2007;7:3-18. Medline:17266502 doi:10.2174/187152007779314044
6. Slyshenkov VS, Moiseenok AG, Wojtczak L. Noxious effects of oxygen reactive species on energy-coupling processes in Ehrlich ascites tumor mitochondria and the protection by pantothenic acid. Free Radic Biol Med. 1996;20:793-800. Medline:8728026 doi:10.1016/0891-5849(95)02210-4
7. Tinggi U. Selenium: its role as antioxidant in human health. Environ Health Prev Med. 2008;13:102-8. Medline:19568888 doi:10.1007/ s12199-007-0019-4
8. Hu YJ, Chen Y, Zhang YQ, Zhou MZ, Song XM, Zhang BZ, et al. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biol Trace Elem Res. 1997;56:331-41. Medline:9197929 doi:10.1007/BF02785304
9. Ciges M, Fernández-Cervilla F, Crespo PV, Campos A. Pantothenic acid and coenzyme A in experimental cisplatin-induced ototoxia. Acta Otolaryngol. 1996;116:263-8. Medline:8725528 doi:10.3109/00016489609137837
10. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol. 1997;40 Suppl:S3-8. Medline:9272126 doi:10.1007/s002800051053
11. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484-90. Medline:3003504 doi:10.1016/S0076-6879(85)13062-4
12. Rice-Evans CA, Diplock AT, Symons MCR. Techniques in free radical research. Amsterdam: Elsevier; 1991.
13. Akerboom TPM, Sies H. Assay for glutathione and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981;77:373-82. Medline:7329314 doi:10.1016/S0076-6879(81)77050-2
14. Verde V, Fogliano V, Ritieni A, Maiani G, Morisco F, Caporaso N. Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma. Free Radic Res. 2002;36:869-73. Medline:12420745 doi:10.1080/1071576021000005302
15. Verevkina IA, Tochilkin AI, Popova NA. Colorimetric method for determination of SH-and SS-groups in proteins connections using 5,5'-dithiobis (2-nitrobenzoic acid). In: Orekhovich, editor. Modern methods in biochemistry [in Russian]. Moscow: Medicine; 1977. p. 223-31.
16. Yeshchenko ND, Volsky GG. Methods for biochemical studies [in Russian]. Leningrad: LSU: 1982.
17. Gavrilov VB, Kravchenko ON, Vetushko DA, Gurevich GL, Konev SV. A new method of estimating damage erythrocytes binding cationic dye [in Russian]. Reports of NAS of Belarus. 2000;44:87-90.
18. Togaybaev AA, Kurguzkina AV, Rikun IV, Karibzhanova PM. Method for diagnosing endogenous intoxication [in Russian]. Lab Delo. 1988;9:22-4. Medline:2461467
19. McDougal DB, Dargar RV. A spectrophotometric cycling assay for reduced coenzyme A and its esters in small amounts of tissue. Anal Biochem. 1979;97:103-15. Medline:484831 doi:10.1016/0003-2697(79)90333-6
20. Abiko Y, Suzuki T, Shimizu M. Investigations on pantothenic acid and its related compounds xi. biochemical studies (6). A final stage in the biosynthesis of CoA. J Biochem. 1967;61:309-12. Medline:6053310
21. Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5:415-8. Medline:11256882 doi:10.1023/A:1009616228304
22. Kaminskyy VO, Zhivotovsky B. Free radicals in crosstalk between autophagy and apoptosis. Antioxid Redox Signal. 2014. Epub ahead of print. Medline:24359220 doi:10.1089/ars.2013.5746
23. Bragado P, Armesilla A, Silva A, Porras A. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis. 2007;12:1733-42. Medline:17505786 doi:10.1007/s10495-007-0082-8
24. Young RC. Drug resistance in cancer therapy. Dordrecht: Kluwer; 1989.
25. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48-58. Medline:11902585 doi:10.1038/nrc706
26. Liu YY, Han TY, Giuliano AE, Cabot MC. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J. 2001;15:719-30. Medline:11259390 doi:10.1096/fj.00-0223com
27. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74:957-67. Medline:8402885 doi:10.1016/0092-8674(93)90719-7
28. Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med. 2001;7:584-90. Medline:11329060 doi:10.1038/87912
29. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010-4. Medline:14963330 doi:10.1126/ science.1092734
30. Muller PA, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol. 2011;192:209-18. Medline:21263025 doi:10.1083/jcb.201009059
31. Aguilar F, Charrondiere UR, Dusemund B, Galtier P, Gilbert J, Gott DM, et al. Pantethine as source for pantothenic acid added as a nutritional substance in food supplements. The EFSA Journal. 2008;865:1-20.